1. Catalytic antioxidant therapy by metallodrugs: lessons from metallocorroles. Issue 27 (9th February 2015) Authors: Haber, Adi; Gross, Zeev Journal: Chemical communications Issue: Volume 51:Issue 27(2015) Page Start: 5812 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ChemInform Abstract: Catalytic Antioxidant Therapy by Metallodrugs: Lessons from Metallocorroles. Issue 22 (15th May 2015) Authors: Haber, Adi; Gross, Zeev Journal: ChemInform Issue: Volume 46:Issue 22(2015) Page Start: no Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CSIG-41. SENSITIZING CANCER CELLS TO TUMOR TREATING FIELDS (TTFIELDS) BY INHIBITION OF PI3K. (14th November 2022) Authors: Klein-Goldberg, Anat; Voloshin, Tali; Zemer-Tov, Efrat; Paz, Rom; Koren, Lilach; Wainer-Katsir, Kerem; Volodin, Alexandra; Koltun, Bella; Brant, Boris; Barsheshet, Yiftah; Kan, Tal; Cohen, Gadi; David, Cfir; Khalil, Tharwat Haj; Haber, Adi; Giladi, Moshe; Weinberg, Uri; Palti, Yoram Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DDRE-46. REDUCED CANCER CELL SENSITIVITY TO TUMOR TREATING FIELDS (TTFields) THROUGH ACTIVATION OF THE PI3K/AKT/mTOR SIGNALING PATHWAY CAN BE MITIGATED USING PI3K INHIBITORS OR PI3K/mTOR DUAL INHIBITORS. (12th November 2021) Authors: Klein-Goldberg, Anat; Voloshin, Tali; Zemer-Tov, Efrat; Paz, Rom; Koren, Lilach; Wainer-Katsir, Kerem; Volodin, Alexandra; Koltun, Bella; Brant, Boris; Haber, Adi; Giladi, Moshe; Weinberg, Uri; Palti, Yoram Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DNAR-10. THE EFFICACY OF TEMOZOLOMIDE AND LOMUSTINE IN GLIOBLASTOMA CELL LINES MAY BE ENHANCED BY CONCOMITANT TREATMENT WITH TUMOR TREATING FIELDS (TTFIELDS). (14th November 2022) Authors: Fishman, Hila; Monin, Roni; Dor-On, Eyal; Haber, Adi; Giladi, Moshe; Weinberg, Uri; Palti, Yoram Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EXTH-74. INCREASING CANCER CELL MEMBRANE PERMEABILITY THROUGH APPLICATION OF TUMOR TREATING FIELDS (TTFIELDS). (12th November 2021) Authors: Voloshin, Tali; Koltun, Bella; Koren, Lilach; Porat, Yaara; Volodin, Alexandra; Kaynan, Noa; Klein-Goldberg, Anat; Paz, Rom; Brant, Boris; Zemer-Tov, Efrat; Haber, Adi; Giladi, Moshe; Weinberg, Uri; Palti, Yoram Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models. (October 2021) Authors: Mumblat, Helena; Martinez-Conde, Antonia; Braten, Ori; Munster, Mijal; Dor-On, Eyal; Schneiderman, Rosa S.; Porat, Yaara; Voloshin, Tali; Davidi, Shiri; Blatt, Roni; Shteingauz, Anna; Tempel-Brami, Catherine; Zeevi, Einav; Lajterer, Carolina; Shmueli, Yuval; Danilov, Shiri; Haber, Adi; Giladi, Mo... Journal: Lung cancer Issue: Volume 160(2021) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗